← Back to Clinical Trials
Recruiting NCT06879977

NCT06879977 Body Awareness in People With Depressive Disorder

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06879977
Status Recruiting
Phase
Sponsor Johannes Kepler University of Linz
Condition Depressive Disorder
Study Type OBSERVATIONAL
Enrollment 125 participants
Start Date 2025-03-26
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 69 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 125 participants in total. It began in 2025-03-26 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Body awareness plays a crucial role in health and well-being. However, too little research has been carried out on how it manifests in individuals with depressive disorders. The Awareness Body Chart (ABC), a tool developed in recent years to assess body awareness, may provide new insights into the physical experience of people with depression and may lead the way in the application of body-oriented therapies in this cohort. Information about the distribution properties of the Awareness Body Chart in people with depressive disorder will be collected and analysed in this observational study.

Eligibility Criteria

Inclusion Criteria: * Age 18 - 69 years * Medical diagnosis of a depressive disorder, including depressive adjustment disorder and depressive episodes in the context of bipolar disorder, i.e. one of the following ICD-10 codes: * F32 Depressive Episode * F33 Recurrent Depressive Disorder * F31.3 Bipolar Affective Disorder, current mild or moderate depressive episode * F31.4 Bipolar Affective Disorder, current severe depressive episode without psychotic symptoms * F43.20 Adjustment Disorder with Brief Depressive Reaction * F43.21 Adjustment Disorder with Prolonged Depressive Reaction * Inpatient admission * Written informed consent Exclusion Criteria: * Inability to fill out questionnaires with or without assistance due to language, physical, or cognitive limitations * Acute psychotic state * Known body schema disorders, e.g. due to significant neurological or malignant diseases, eating disorders, congenital or acquired physical limitations such as the absence of a body part * Deafness, blindness

Contact & Investigator

Central Contact

Christian Mittermaier, M.D.

✉ Christian.Mittermaier@kepleruniklinikum.at

📞 +43 (0)5 7680 83 - 6170

Frequently Asked Questions

Who can join the NCT06879977 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 69 Years, studying Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06879977 currently recruiting?

Yes, NCT06879977 is actively recruiting participants. Contact the research team at Christian.Mittermaier@kepleruniklinikum.at for enrollment information.

Where is the NCT06879977 trial being conducted?

This trial is being conducted at Linz, Austria.

Who is sponsoring the NCT06879977 clinical trial?

NCT06879977 is sponsored by Johannes Kepler University of Linz. The trial plans to enroll 125 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology